Recap: Inari Medical Q4 Earnings
Portfolio Pulse from Benzinga Insights
Inari Medical (NASDAQ:NARI) reported Q4 earnings with an EPS of $-0.08, missing estimates by -900.0% against an expected $0.01. Revenue increased by $24.32 million from the previous year. Despite beating EPS estimates in Q3 2023, the share price dropped by 17.0% the following day.
February 28, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Inari Medical reported a significant miss in Q4 earnings with an EPS of $-0.08 against an expected $0.01, and a revenue increase of $24.32M from last year.
The significant miss in earnings expectations (-900%) is likely to negatively impact investor sentiment and could lead to a decrease in stock price, similar to the 17% drop observed after the last quarter's earnings beat. The increase in revenue may not be sufficient to offset the negative impact of the earnings miss.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100